The Challenge With Today’s Value Assessments: Not Evolving With the Evidence

There are many ways to assess cost—yet as new evidence surfaces about a therapy’s efficacy, original cost assessments may not change. Larry Blandford, Executive VP, Customer Solutions, Precision Value & Health, believes evolving the current assessment model is essential: To address concerns about soaring healthcare cost, focus on value.

Read the article

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.